Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eulactol Heel Balm (marketed as Scholl Eulactol Heel Balm Gold) is a topical emollient and keratolytic cream containing 25% chemically synthesised urea. It is indicated for the treatment of xerosis (dry, rough, cracked skin) of the foot, including cracked heels. Urea acts as a humectant at lower concentrations and as a keratolytic agent at higher concentrations (such as the 25% formulation in Eulactol), where it disrupts hydrogen bonds in keratin proteins within the stratum corneum to promote desquamation and skin hydration. The product was evaluated in a completed Australian comparative clinical trial sponsored by the University of South Australia, which compared its efficacy, patient satisfaction, and cost-benefit profile against Walker's Sorbolene over a 4-week period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eulactol Heel Balm.